Related Experiment Video
Updated: May 10, 2026
02:49
A Swine Burn Model for Investigating the Healing Process in Multiple Depth Burn Wounds
Published on: February 23, 2024
Curbing inflammation in burn patients.
Jayme A Farina1, Marina Junqueira Rosique, Rodrigo G Rosique
1Department of Surgery and Anatomy, Division of Plastic Surgery, School of Medicine of Ribeirão Preto-SP, University of São Paulo, Avenida Bandeirantes 3900, 9.°andar, 14048-900 Ribeirão Preto SP, Brazil.
International Journal of Inflammation
|June 14, 2013
Summary
Severe burn injuries cause metabolic issues and systemic inflammatory response syndrome (SIRS), leading to organ failure. This review explores therapies to reduce inflammation, highlighting the need for more high-quality evidence on burn treatments.
Area of Science:
- Burn injury research
- Inflammation and immunology
- Trauma and critical care medicine
Background:
- Severe burns trigger metabolic disturbances and systemic inflammatory response syndrome (SIRS).
- SIRS in burn patients can lead to multiple organ dysfunction and mortality.
- Understanding inflammatory pathways is crucial for developing effective burn treatments.
Purpose of the Study:
- To review current strategies for mitigating inflammation in severe burn injuries.
- To synthesize recent research insights into burn injury therapies.
- To identify gaps in evidence regarding anti-inflammatory treatments for burns.
Main Methods:
- Literature review of studies on burn injury and inflammation.
- Analysis of therapeutic strategies targeting inflammatory processes.
- Synthesis of findings on the efficacy of different interventions.
Main Results:
- Various strategies exist to manage inflammation post-burn injury.
- Current research provides insights into modulating the inflammatory response.
- Evidence quality varies across different therapeutic approaches.
Conclusions:
- Effective management of burn-induced inflammation is critical for patient outcomes.
- Further high-quality research is essential to validate and refine burn treatment strategies.
- Targeting inflammation remains a key focus in advancing critical care for burn survivors.
Related Concept Videos
01:22Burn Injuries
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Decreased Body Temperature
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...